PKCβ is divided into two isoforms, PKCβI and PKCβII, by selective splicing of the PRKCB1 gene, which play key regulatory roles in a variety of physiological and pathological processes, particularly in metabolic disease complications, tumorigenesis, inflammatory responses, and cell death pathways [58, 59, 60]. This evidence concerns the gene PRKCB and metabolic disease.